WO2009058285A3 - PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF - Google Patents

PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF Download PDF

Info

Publication number
WO2009058285A3
WO2009058285A3 PCT/US2008/012251 US2008012251W WO2009058285A3 WO 2009058285 A3 WO2009058285 A3 WO 2009058285A3 US 2008012251 W US2008012251 W US 2008012251W WO 2009058285 A3 WO2009058285 A3 WO 2009058285A3
Authority
WO
WIPO (PCT)
Prior art keywords
porcine
new
sign
nucleotide sequence
lsectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/012251
Other languages
French (fr)
Other versions
WO2009058285A2 (en
WO2009058285A9 (en
Inventor
Yaowei Huang
Xiang-Jin Meng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Tech Intellectual Properties Inc
Original Assignee
Virginia Tech Intellectual Properties Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CN2008801240560A priority Critical patent/CN102066415A/en
Priority to US12/739,744 priority patent/US8415118B2/en
Priority to CA2704207A priority patent/CA2704207A1/en
Priority to NZ584893A priority patent/NZ584893A/en
Priority to BRPI0818477 priority patent/BRPI0818477A2/en
Priority to EP08844649A priority patent/EP2207798A2/en
Priority to AU2008319384A priority patent/AU2008319384A1/en
Priority to JP2010532042A priority patent/JP2011501958A/en
Application filed by Virginia Tech Intellectual Properties Inc filed Critical Virginia Tech Intellectual Properties Inc
Priority to MX2010004548A priority patent/MX2010004548A/en
Publication of WO2009058285A2 publication Critical patent/WO2009058285A2/en
Publication of WO2009058285A9 publication Critical patent/WO2009058285A9/en
Publication of WO2009058285A3 publication Critical patent/WO2009058285A3/en
Priority to ZA2010/02773A priority patent/ZA201002773B/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to the cloning, identification and characterization of the unique and entire genomic sequences encoding new porcine DC-SIGN and LSECtin proteins, including the novel nucleotide sequences of the full-length cDNA and genes of both pDC- SIGN gene and pLSECtin. Also provided are the nucleic acid molecules encoding newly discovered porcine ICAM-3 isoforms from porcine monocyte-derived dendritic cells and the use thereof. Specifically, the invention is drawn to an isolated nucleic acid molecule comprising a nucleotide sequence encoding one or more of porcine DC-SIGN, porcine ICAM- 3, porcine LSECtin, a complement of the nucleotide sequence or a functional, defined portion of the nucleotide sequence or a protein fusion product linked to a protein that may be of porcine or human origin. Methods for isolating and cloning the new porcine genes and for using the new nucleotide sequences in improved methods for propagating viruses, particularly enveloped viruses, are additionally described herein. The invention further includes new transfected cells or cell lines that can stably express the porcine proteins, new antibodies and the like.
PCT/US2008/012251 2007-10-29 2008-10-29 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF Ceased WO2009058285A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2008319384A AU2008319384A1 (en) 2007-10-29 2008-10-29 Porcine DC-SIGN , ICAM-3 and LSECtin and uses thereof
CA2704207A CA2704207A1 (en) 2007-10-29 2008-10-29 Porcine dc-sign, icam-3 and lsectin and uses thereof
NZ584893A NZ584893A (en) 2007-10-29 2008-10-29 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
BRPI0818477 BRPI0818477A2 (en) 2007-10-29 2008-10-29 DC-SIGN, ICAM-3 AND LSECTIN PIGS AND USES
EP08844649A EP2207798A2 (en) 2007-10-29 2008-10-29 Porcine dc-sign, icam-3 and lsectin and uses thereof
JP2010532042A JP2011501958A (en) 2007-10-29 2008-10-29 Porcine DC-SIGN, ICAM-3 and LSECtin and their use
MX2010004548A MX2010004548A (en) 2007-10-29 2008-10-29 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF.
CN2008801240560A CN102066415A (en) 2007-10-29 2008-10-29 Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof
US12/739,744 US8415118B2 (en) 2007-10-29 2008-10-29 Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof
ZA2010/02773A ZA201002773B (en) 2007-10-29 2010-04-20 Porcine dc-sign,icam-3 and lsectin and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80007P 2007-10-29 2007-10-29
US61/000,800 2007-10-29

Publications (3)

Publication Number Publication Date
WO2009058285A2 WO2009058285A2 (en) 2009-05-07
WO2009058285A9 WO2009058285A9 (en) 2009-07-09
WO2009058285A3 true WO2009058285A3 (en) 2009-12-10

Family

ID=40591693

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/012251 Ceased WO2009058285A2 (en) 2007-10-29 2008-10-29 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF

Country Status (14)

Country Link
US (1) US8415118B2 (en)
EP (2) EP2207798A2 (en)
JP (1) JP2011501958A (en)
KR (1) KR20100087344A (en)
CN (1) CN102066415A (en)
AU (1) AU2008319384A1 (en)
BR (1) BRPI0818477A2 (en)
CA (1) CA2704207A1 (en)
CO (1) CO6270367A2 (en)
MX (1) MX2010004548A (en)
NZ (1) NZ584893A (en)
RU (1) RU2010121862A (en)
WO (1) WO2009058285A2 (en)
ZA (1) ZA201002773B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201503351RA (en) 2010-01-19 2015-06-29 Harvard College Engineered Opsonin for Pathogen Detection and Treatment
CA3149018A1 (en) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2798069B1 (en) 2011-12-15 2017-03-29 Washington University Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
CN104284984B (en) 2012-02-29 2017-10-13 哈佛大学校长及研究员协会 Rapid Test for Antibiotic Susceptibility
JP6254146B2 (en) 2012-03-27 2017-12-27 エヌジーエム バイオファーマシューティカルス，インコーポレーテッド Compositions and methods for treating metabolic disorders
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
EP3848045A1 (en) 2013-05-21 2021-07-14 President and Fellows of Harvard College Engineered heme-binding compositions and uses thereof
US10513546B2 (en) 2013-12-18 2019-12-24 President And Fellows Of Harvard College CRP capture/detection of gram positive bacteria
JP6704358B2 (en) 2014-07-30 2020-06-03 エヌジーエム バイオファーマシューティカルズ インコーポレイテッド Compositions and methods of use for treating metabolic disorders
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
CN106687128B (en) 2014-10-31 2022-05-10 Ngm生物制药有限公司 Compositions and methods for treating metabolic disorders
CN104749361B (en) * 2015-01-21 2017-04-19 中国农业科学院哈尔滨兽医研究所 porcine circovirus type 2 antigen capture ELISA kit
CN105445457B (en) * 2015-03-24 2017-08-11 中国农业科学院哈尔滨兽医研究所 Detect the monoclonal antibody and kit of carrying Cap gene of porcine circovirus type 2
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN106957847A (en) * 2017-05-16 2017-07-18 吉林大学 Effectively suppress the siRNA and purposes of piglet epidemic diarrhea virus
CN107488635A (en) * 2017-09-22 2017-12-19 中国人民解放军第三军医大学第三附属医院 Monoclonal cell and its production and use
CN108893474B (en) * 2018-02-07 2021-11-16 电子科技大学 Separation and identification of adhesion molecule gene between grass carp cells
CN108977444A (en) * 2018-06-28 2018-12-11 西南大学 The siRNA and screening technique of silencing Rongchang Pig CD14 expression and application
CN109679952B (en) * 2018-12-24 2022-04-15 西北农林科技大学 Porcine-derived miR-c89 for resisting PRRSV infection and application thereof
CN109652384B (en) * 2019-02-21 2021-10-26 昆明理工大学 Method for culturing hepatitis E virus in vitro
CN109836478B (en) * 2019-03-19 2022-06-14 扬州大学 Preparation method and application of African swine fever virus P11.5 protein specific polyclonal antibody
CN109943536B (en) * 2019-03-26 2021-09-14 昆明理工大学 Method for culturing hepatitis E virus and method for preparing inactivated vaccine thereof
CN111575409B (en) * 2020-05-23 2023-04-18 黑龙江八一农垦大学 Research method for inhibiting porcine epidemic diarrhea virus infection based on integrin ligand recognition peptide
WO2022050476A1 (en) * 2020-09-04 2022-03-10 이형우 Composition for treating human immunodeficiency virus infection or infectious diseases
CN115725656B (en) * 2021-09-01 2026-01-16 联邦生物科技(珠海横琴)有限公司 A method for delivering interfering RNA using cytoplasmic RNA viruses as vectors
CN121454060A (en) * 2026-01-05 2026-02-03 江苏立维斯德生物技术有限公司 Method and kit for detecting rotavirus based on immunofluorescence method and application of kit

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005014040A2 (en) * 2003-08-05 2005-02-17 The Royal Veterinary College Antigen delivery system
WO2005113003A2 (en) * 2004-04-16 2005-12-01 Genentech, Inc. Method for augmenting b cell depletion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3623230B2 (en) * 1992-06-11 2005-02-23 ニューヨーク・ユニバーシティ Chimeric receptor polypeptide, human H13 protein, and uses thereof
GB9409768D0 (en) 1994-05-16 1994-07-06 Medical Res Council Trimerising polypeptides
US6146873A (en) 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US6280953B1 (en) 1998-01-30 2001-08-28 Evolutionary Genomics, L.L.C. Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
EP1179015A1 (en) * 1999-03-25 2002-02-13 Bristol-Myers Squibb Company Dna molecules encoding human clax proteins and their soluble fusion proteins
US6365156B1 (en) 1999-04-16 2002-04-02 Osel, Inc. Method for improving the half-life of soluble viral-specific ligands on mucosal membranes
EP1046651A1 (en) 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition and method for modulating dendritic cell-T interaction
US6391567B1 (en) 2000-03-02 2002-05-21 New York University Identifying compounds inhibiting DC-sign facilitation of HIV into cells

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005014040A2 (en) * 2003-08-05 2005-02-17 The Royal Veterinary College Antigen delivery system
WO2005113003A2 (en) * 2004-04-16 2005-12-01 Genentech, Inc. Method for augmenting b cell depletion

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 14 October 2004 (2004-10-14), "Sus scrofa mRNA, clone:MLN01F030001, 5' end, expressed in mesenteric lymph node.", XP002532928, retrieved from EBI accession no. EMBL:CJ007777 Database accession no. CJ007777 *
DATABASE EMBL [online] 16 September 2006 (2006-09-16), "Sus scrofa mRNA, clone:LVR010098C02, expressed in liver.", XP002549385, retrieved from EBI accession no. EMBL:AK232603 Database accession no. AK232603 *
DATABASE EMBL [online] 16 September 2006 (2006-09-16), "Sus scrofa mRNA, clone:LVRM10084C09, expressed in liver.", XP002549383, retrieved from EBI accession no. EMBL:AK233123 Database accession no. AK233123 *
DATABASE EMBL [online] 16 September 2006 (2006-09-16), "Sus scrofa mRNA, clone:THY010118A12, expressed in thymus.", XP002549382, retrieved from EBI accession no. EMBL:AK239636 Database accession no. AK239636 *
DATABASE EMBL 17 September 2007 (2007-09-17), "intercellular adhesion molecule 3 precursor [Homo sapiens]", XP002549384, retrieved from NCBI Database accession no. NP_002153 *
DATABASE EMBL 26 September 2007 (2007-09-26), "C-type lectin superfamily 4, member G [Homo sapiens]", XP002549386, retrieved from NCBI Database accession no. NP_940894 *
DATABASE GENBANK [online] 26 September 2007 (2007-09-26), "Homo sapiens CD209 molecule (CD209), mRNA.", XP002532929, retrieved from NCBI Database accession no. NM_021155 *
DOMINGUEZ-SOTO ANGELES ET AL: "The DIC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells", BLOOD, vol. 109, no. 12, June 2007 (2007-06-01), pages 5337 - 5345, XP002549381, ISSN: 0006-4971 *
FAWCETT JONATHAN ET AL: "Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes", NATURE (LONDON), vol. 360, no. 6403, 1992, pages 481 - 484, XP002549379, ISSN: 0028-0836 *
GEIJTENBEEK TEUNIS B H ET AL: "Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 100, no. 5, 3 March 2000 (2000-03-03), pages 575 - 585, XP000929197, ISSN: 0092-8674 *
HALARY F ET AL: "Human cytomegalovirus binding to DC - SIGN is required for dendritic cell infection and target cell trans-infection", IMMUNITY, CELL PRESS, US, vol. 17, 1 November 2002 (2002-11-01), pages 653 - 664, XP002272515, ISSN: 1074-7613 *
LIU WANLI ET AL: "Characterization of a novel C-type lectin-like gene, LSECtin - Demonstration of carbohydrate node", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 18, 30 April 2004 (2004-04-30), pages 18748 - 18758, XP002549380, ISSN: 0021-9258 *
TASSANEETRITHEP BOONRAT ET AL: "DC - SIGN (CD209) mediates dengue virus infection of human dendritic cells", JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, JP, vol. 197, no. 7, 7 April 2003 (2003-04-07), pages 823 - 829, XP002272514, ISSN: 0022-1007 *

Also Published As

Publication number Publication date
NZ584893A (en) 2012-08-31
WO2009058285A2 (en) 2009-05-07
RU2010121862A (en) 2011-12-10
EP2207798A2 (en) 2010-07-21
US8415118B2 (en) 2013-04-09
MX2010004548A (en) 2010-05-05
CO6270367A2 (en) 2011-04-20
BRPI0818477A2 (en) 2015-04-14
KR20100087344A (en) 2010-08-04
AU2008319384A1 (en) 2009-05-07
WO2009058285A9 (en) 2009-07-09
CN102066415A (en) 2011-05-18
ZA201002773B (en) 2011-10-26
CA2704207A1 (en) 2009-05-07
EP2662384A1 (en) 2013-11-13
JP2011501958A (en) 2011-01-20
US20100317054A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
MX2010004548A (en) PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF.
AU2020259548B2 (en) Methods and compositions for editing RNAs
AU2019357450B2 (en) Methods and compositions for editing RNAs
US20250101400A1 (en) Novel crispr enzymes and systems
CN113227367B (en) Compositions and methods for genome engineering with CAS12A protein
CN101896616B (en) Compositions and methods for improved glycoprotein sialylation
WO2006042158A3 (en) Methods and compositions for improving recombinant protein production
JP2020510443A (en) Method for increasing the efficiency of homologous recombination repair (HDR) in a cell genome
IL303505A (en) Preparations and methods for reducing MHC CLASS II in the cell
WO2022150974A1 (en) Targeted rna editing by leveraging endogenous adar using engineered rnas
CA2948728A1 (en) Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10)
Charton et al. Exploiting the CRISPR/Cas9 system to study alternative splicing in vivo: application to titin
WO2020041384A1 (en) 3-phenyl-2-cyano-azetidine derivatives, inhibitors of rna-guided nuclease activity
WO2023178294A2 (en) Compositions and methods for improved protein translation from recombinant circular rnas
CA2752947A1 (en) Foxp1 splice variants and methods and uses thereof
MX2007011425A (en) Cis-acting regulatory elements from tripsacum dactyloides.
EP3866860B1 (en) Complement component 1s (c1s) deficient cells for production of vaccines and biopharmaceutical proteins
Ohishi et al. A forward genetic screen to study mammalian RNA interference–essential role of RNase IIIa domain of Dicer1 in 3′ strand cleavage of dsRNA in vivo
Fischer et al. Xylosyltransferase-deficient human HEK293 cells show a strongly reduced proliferation capacity and viability
KR101873327B1 (en) Novel homing endonuclease from arabidopsis thaliana
CN119177217B (en) Use of PARIT a1 to promote stem cell multipotency maintenance and reprogramming
CN110157711B (en) Method for cloning full-length segment of coding region of human srebp1 gene
HK40081918B (en) Methods and compositions for editing rna
HK40081918A (en) Methods and compositions for editing rna
CN120882867A (en) Type II CAS protein and its application

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880124056.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08844649

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12739744

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1463/KOLNP/2010

Country of ref document: IN

Ref document number: 584893

Country of ref document: NZ

Ref document number: MX/A/2010/004548

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 10050942A

Country of ref document: CO

Ref document number: 2704207

Country of ref document: CA

Ref document number: 10050942

Country of ref document: CO

Ref document number: 12010500952

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010532042

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2008844649

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008319384

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 20107011603

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2010121862

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2008319384

Country of ref document: AU

Date of ref document: 20081029

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0818477

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100429